During her PhD in Sciences from ETHZ, Daniela focused her research on vascular biology and stem cells. She then joined a research group at UZH as post doc and before starting CUTISS, she was the co-leader and business developer for the project denovoSkin™ at the Wyss Zurich. 

She co-founded CUTISS, where denovoSkin™ is being developed towards commercialization. Worldwide, millions of people suffer from skin defects requiring surgical interventions to restore skin function. Current standard of care to treat large, deep skin defects is often not available in sufficient quantities, and it frequently leaves these patients with permanent, painful, disfiguring, and debilitating scars. denovoSkin™ is a personalized human skin graft that can be bio-engineered in large quantities. It promises to grow with the patient, limit scarring, and drastically reduce the number of follow up corrective surgeries required, particularly in children. 

It is currently in Phase 2 clinical trials and could be of great benefit for patients with burns, traumas, that undergo reconstructive or plastic procedures.